Representative before the EPO

Company dna hsf pharmaceuticals sa
no operation time available
1 office
active in Legal Services

Representative before the EPO

Company dna voellmy patent attorney
no operation time available
1 office
active in Legal Services

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Lukas Völlmy has worked on the following 22 EPO patent applications which have been published in the last five years:

EP12704407

CEFUROXIME SAFETY DELIVERY SYSTEM

IPC classification:
A61J 1/20, A61K 9/00, A61M 5/178, A61M 5/19, A61M 5/24, A61M 5/315
Agent:
Lukas Völlmy, VOELLMY (Patent Attorney)
Status:
EXAMINATION IN PROGRESS
EP12710051

THERMO-RESPONSIVE HYDROGEL COMPOSITIONS

IPC classification:
A61K 47/32, A61K 47/48
Agent:
Lukas Völlmy, VOELLMY (Patent Attorney)
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12812651

ENZYMATIC CONJUGATION OF ANTIBODIES

IPC classification:
A61K 47/48, A61P 35/00
Applicant:
Paul Scherrer Institut
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
GRANT OF PATENT INTENDED
EP13704064

MICA BINDING AGENTS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION IN PROGRESS
EP14191805

Transglutaminase mediated conjugation of peptides

IPC classification:
A61K 38/27, A61K 47/48, C07K 14/61, C12P 21/00
Applicant:
Novo Nordisk Health Care AG
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
PATENT GRANTED
EP13765703

KIR3DL2 BINDING AGENTS

IPC classification:
C07K 16/28, G01N 33/569
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION IN PROGRESS
EP13765702

KIR3DL2 BINDING AGENTS

IPC classification:
C07K 16/28, G01N 33/569
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION IN PROGRESS
EP13791777

RECOGNITION TAGS FOR TGASE-MEDIATED CONJUGATION

IPC classification:
A61K 47/48
Applicant:
Paul Scherrer Institut
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION IN PROGRESS
EP14704576

TREATMENT OF PERIPHERAL T CELL LYMPHOMA

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30
Applicant:
Innate Pharma SA
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION IN PROGRESS
EP14706017

A COMPOUND THAT SPECIFICALLY BINDS TO KIR3DL2 FOR USE IN THE TREATMENT OF PERIPHERAL T CELL LYMPHOMA

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION IN PROGRESS
EP14723452

METHODS FOR RESTORING CORTICOSTEROID SENSITIVITY

IPC classification:
A61K 39/00, A61K 39/395, A61P 11/00, A61P 19/02, A61P 37/00, C07K 16/28
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION IN PROGRESS
EP14731962

ENZYMATIC CONJUGATION OF POLYPEPTIDES

IPC classification:
A61K 47/48
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
GRANT OF PATENT INTENDED
EP14734427

ENZYMATIC CONJUGATION OF POLYPEPTIDES

IPC classification:
A61K 47/48
Applicant:
Paul Scherrer Institut
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
GRANT OF PATENT INTENDED
EP15709212

HUMANIZED ANTIBODIES WITH INCREASED STABILITY

IPC classification:
A61K 39/00, A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30
Applicant:
Innate Pharma SA
Agent:
Valérie Gallois, Cabinet Becker & Associés
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION REQUESTED
EP15731564

MULTISPECIFIC NKp46 BINDING PROTEINS

IPC classification:
C07K 16/28, C07K 16/46
Applicant:
Innate Pharma SA
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
EXAMINATION REQUESTED
EP15762508

NOVEL IMMUNIZATION AGENTS AND METHODS OF USE

IPC classification:
A61K 39/00, A61K 39/12
Agent:
Lukas Völlmy, HSF Pharmaceuticals SA
Status:
EXAMINATION REQUESTED
EP15784928

MANAGING NETWORK FORWARDING CONFIGURATIONS USING ALGORITHMIC POLICIES

IPC classification:
H04L 12/24
Agent:
Lukas Völlmy, HSF Pharmaceuticals SA
Status:
Request for examination was made
EP15762562

CROSS REACTIVE SIGLEC ANTIBODIES

IPC classification:
A61P 35/00, C07K 16/28
Applicant:
Innate Pharma SA
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
Request for examination was made
EP15763016

TREATMENT REGIMENS USING ANTI-NKG2A ANTIBODIES

IPC classification:
A61K 39/00, A61K 39/395, A61P 29/00, A61P 35/00, C07K 16/28
Applicant:
Innate Pharma SA
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
Request for examination was made
EP15766120

NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES

IPC classification:
A61K 39/00, A61K 39/395, A61P 35/00, C07K 16/28
Applicant:
Innate Pharma SA
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
Request for examination was made
EP15778310

CD73 BLOCKADE

IPC classification:
C07K 16/28, C07K 16/30, C07K 16/40
Applicant:
Innate Pharma SA
Agent:
Lukas Völlmy, Innate Pharma SA
Status:
Request for examination was made

Please Sign in to use this feature